-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Orchard Therapeutics plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q3 2023.
- Orchard Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $2.47M, a 28.8% decline year-over-year.
- Orchard Therapeutics plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $12.5M, a 28.3% decline year-over-year.
- Orchard Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $16M, a 29% decline from 2021.
- Orchard Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $22.5M, a 19.4% decline from 2020.
- Orchard Therapeutics plc annual Share-based Payment Arrangement, Expense for 2020 was $28M, a 44% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)